The epidemiological evidence linking Helicobacter pylori infection to gastric carcinogenesis is reviewed. Only large geographical population studies have revealed a positive correlation between H. pylori infection and the incidence or mortality of gastric cancer.
Gastric cancer is a common disease worldwide. In Japan, the incidence of gastric cancer per 100,000 has gradually decreased from approximately 78.8 for males and 46. 3 
for females in 19801)
Nevertheless, approximately 60,000 patients died of gastric adenocarcinoma in 1994. In other parts of the world, such as China, other Asian countries, Western South America and Central America, the mortality rate from this cancer is higher than 30 per 100,000 among males. In the United States, the mortality rate per 100,000 was approximately 6 in 1985, and has remained stable over the past several years. These different rates are suggested to be associated with variations in dietary and environmental factors. Geographical studies A geographical study in 46 rural counties of the People's Republic of China revealed a weak but significant correlation between the prevalence of H. Pylori antibodies and the gastric cancer mortality rate9). This significant positive correlation remained even after adjusting for dietary factors known to be associated with an increasing gastric cancer risk. In 1992, a sex-specific correlation and multivariate regression analysis10) showed a significant positive correlation with the consumption of salted vegetables and eggs, the prevalence of H. Pylori antibodies, and the plasma albumin level, as well as a significant negative correlation with the intake of green vegetables and These results suggested that H. Pylori infection might be a determinant of the geographical variations in gastric cancer risk that was independent of diet, because the prevalence of H. Pylori antibodies ranged from 27% to 96% in the counties for which data were available10).
On the other hand, a positive correlation with H. Pylori was not found in two other geographical studies. These results suggested that some unknown factors may have decreased the prevalence of H. Pylori antibodies during the progression of gastric cancer. H. Pylori finds it difficult to colonize site of intestinal metaplasia in the stomach20), probably due to the loss of receptors21,22) on the metaplastic cells and/or the active production of specific secretory IgA for H. Pylori by metaplastic mucosa23). The extent of intestinal metaplasia is closely related to the grade of gastric atrophy. Accordingly, they performed conditional logistic regression analysis to adjust for the negative effect of advanced intestinal metaplasia by using the pepsinogen I/ II ratio24). After adjustment for the grade of gastric atrophy, patients with gastric cancer showed a significantly higher 2.81) ( Table 2 ). In particular, the intestinal type of gastric cancer showed a strong association with H. Pylori infection when compared to the diffuse type (odds ratio: 3.76 vs 1.14).
Three cohort (nested case-control) studies have shown consistent results (Table 3 ). In these studies, H. Pylori antibodies were measured in serum collected several years prior to the diagnosis of gastric cancer. In an UK study25), the prevalence of H. Pylori antibodies in 29 men with a subsequent diagnosis of gastric cancer (the interval between sampling and diagnosis was less than 5 years in 11 subjects and 5-14 years in 18.) was compared with that in 116 controls matched for the date of birth and date of blood sampling from among over 22,000 middle-aged men. The odds ratio for gastric cancer in the individuals with 7.97), although the study size was limited.
The second study26) was conducted in a cohort of Japanese American men living in Hawaii. The 109 patients with gastric cancer in this cohort were enrolled, while control subjects matched for age and the date of serum collection were selected from among approximately 6,000 men. The average time from serum collection to diagnosis of gastric infection was found for both intestinal and diffuse types of cancer, and was stronger when the diagnosis was made 10 or more years after serum collection (odds ratio: 10.5). Numerous independent studies have shown that chronic gastritis, especially atrophic gastritis, is a precancerous condition (Fig. 1) . It has been shown that the spread of mucosal atrophy is accelerated by H. Pylori infection in clinical28,29) and animal studies30). The current hypothesis is that chronic inflammation due to H. Pylori infection accelerates the proliferation of gastric epithelial cells and potentiates the risk of DNA damage by endogenous mutagens31) generated by infiltrating inflammatory cells (e. g.; superoxide and hydroxyl radicals) and by exogenous mutagens ingested in foods. As atrophy involves the fundic glands, acid secretion decreases and commensual bacteria can colonize the stomach more easily. These bacteria may reduce nitrate to nitrite, leading to the production of carcinogenic nitrosamines, and may promote the generation of nitric oxide by inflammatory cells. Additionally, H. Pylori infection affects the intragastric secretion of ascorbic acid32), which is an anti-oxidants and prevents the formation of nitrosamines (Fig. 2) . However, the high prevalence of H. Pylori infection in developing countries (Fig. 3) 33,34) with a low incidence of gastric cancer indicates that only a small population of infected patients will develop cancer, even if gastric atrophy progresses with aging. Therefore, other risk factors also appear to be involved in the development of gastric cancer. Yemeni patients had a significantly higher prevalence of H. Pylori infection than British patients, (92% vs 46%), Yemeni patients show a significantly lower prevalence of all types of intestinal metaplasia (19% vs 34%). This is particularly true for type III intestinal metaplasia (3% vs 22%), which is a major risk factor for a gastric cancer.
These findings suggest that genetic or the environmental factors may be involved in the development of gastric cancer or in the progression of the dysplasia-carcinoma sequence.
An alternative explanation could be the presence of different strains of H. Pylori with a varying oncogenic potential. 
